An essential role for insulin and IGF1 receptors in regulating sertoli cell proliferation, testis size, and FSH action in mice. by Pitetti, Jean-Luc et al.
An essential role for insulin and IGF1 receptors in
regulating sertoli cell proliferation, testis size, and FSH
action in mice.
Jean-Luc Pitetti, Pierre Calvel, Ce´line Zimmermann, Be´atrice Conne,
Marilena D Papaioannou, Florence Aubry, Christopher R Cederroth,
Franc¸oise Urner, Betty Fumel, Michel Crausaz, et al.
To cite this version:
Jean-Luc Pitetti, Pierre Calvel, Ce´line Zimmermann, Be´atrice Conne, Marilena D Papaioannou,
et al.. An essential role for insulin and IGF1 receptors in regulating sertoli cell proliferation,
testis size, and FSH action in mice.. Molecular Endocrinology -Baltimore-, Endocrine Society,
2013, 27 (5), pp.814-27. <10.1210/me.2012-1258>. <hal-00877005>
HAL Id: hal-00877005
https://hal.archives-ouvertes.fr/hal-00877005
Submitted on 25 Oct 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
An Essential Role for Insulin and IGF1 Receptors in
Regulating Sertoli Cell Proliferation, Testis Size, and
FSH Action in Mice
Jean-Luc Pitetti, Pierre Calvel, Céline Zimmermann, Béatrice Conne,
Marilena D. Papaioannou, Florence Aubry, Christopher R. Cederroth,
Françoise Urner, Betty Fumel, Michel Crausaz, Mylène Docquier,
Pedro Luis Herrera, François Pralong, Marc Germond, Florian Guillou,
Bernard Jégou, and Serge Nef
Department of Genetic Medicine and Development (J.-L.P., P.C., C.Z., B.C., M.D.P., C.R.C., P.L.H., S.N.),
University of Geneva Medical School and Genomics Platform (M.D.), National Center of Competence in
Research “Frontiers in Genetics,” University of Geneva, 1211 Geneva 4, Switzerland; Department of
Internal Medicine (F.P.), University Hospital, 1011 Lausanne, Fondation pour l’Andrologie, la Biologie et
l’Endocrinologie de la Reproduction and Centre for Medically Assisted Procreation (F.U., M.C., M.G.),
1003 Lausanne, Switzerland; Unité Physiologie de la Reproduction et des Comportements (B.F., F.G.),
Unité Mixte de Recherche 6175, Institut National de la Recherche Agronomique-Centre National de la
Recherche Scientifique-Université de Tours-Haras Nationaux, 37380 Nouzilly, France; and Institut
National de la Santé et de la Recherche Médicale (F.A., B.J.), U625, Université Rennes I, Institut Fédératif
de Recherche 140, Groupe d’Etude sur la Reproduction chez l’Homme et le Mammifère, F-35042,
Rennes, France
Testis size and sperm production are directly correlated to the total number of adult Sertoli cells
(SCs). Although the establishment of an adequate number of SCs is crucial for futuremale fertility,
the identification and characterization of the factors regulating SC survival, proliferation, and
maturation remain incomplete. To investigate whether the IGF system is required for germ cell
(GC) and SC development and function, we inactivated the insulin receptor (Insr), the IGF1 recep-
tor (Igf1r), or both receptors specifically in theGC lineage or in SCs.Whereas ablation of insulin/IGF
signaling appears dispensable for GCs and spermatogenesis, adult testes of mice lacking both Insr
and Igf1r in SCs (SC-Insr;Igf1r) displayed a 75% reduction in testis size and daily sperm production
as a result of a reduced proliferation rate of immature SCs during the late fetal and early neonatal
testicular period. In addition, in vivo analyses revealed that FSH requires the insulin/IGF signaling
pathway tomediate its proliferative effects on immature SCs. Collectively, these results emphasize
the essential role played by growth factors of the insulin family in regulating the final number of
SCs, testis size, and daily sperm output. They also indicate that the insulin/IGF signaling pathway
is required for FSH-mediated SC proliferation. (Molecular Endocrinology 27: 814–827, 2013)
Spermatogenesis refers to a complex differentiationprocess by which diploid spermatogonial stem cells
develop into mature haploid spermatozoa. In the adult,
Sertoli cells (SCs), the only somatic constituents of the
seminiferous epithelium, are in direct physical association
with all types of germ cells (GCs) and are mainly commit-
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Abbreviations: CASA, computer-assisted sperm analysis; E, embryonic day; FSHR, FSH
receptor; GC, germ cell; GFP, green fluorescent protein; hCG, human chorionic gonado-
tropin; H&E, hematoxylin and eosin; 3-HSD, 3-hydroxysteroid dehydrogenase; IF, im-
munofluorescence; IGF1R, type I insulin-like growth factor receptor; IHC, immunohisto-
chemistry; INSR, insulin receptor; LC, Leydig cell; MAPK,mitogen-activated protein kinase;
P, postnatal day; PFA, paraformaldehyde; PI, propidium iodide; PI3K, phosphatidylinositol
3-kinase; PMC, peritubular myoid cell; PTU, 6-propyl-2-thiouracil; q, quantitative; SC,
Sertoli cell; SMA, smooth muscle actin; TUNEL, terminal deoxynucleotidyl transferase
dUTP nick-end labeling.
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ted to sustain spermatogenesis. In particular, SCs provide
GCs with a structural support and a preserved environ-
ment with the blood-testis barrier, assist their movement
toward the seminiferous epithelium lumen and sustain
their development through their secretory products (for
reviews, see Refs. 1 and 2). Notably, individual SCs can
only support a finite number of GCs. Therefore, the final
testis size, the number of GCs in the adult testis, and
sperm output are directly linked to the total number of
SCs (3). It has been well established that the SC prolifer-
ation window in mice occurs during late fetal and early
neonatal testicular development and the final adult num-
ber is reached by postnatal day (P) 15 (4, 5). This creates
a stable, nondividing SC population that matures and
progressively acquires the ability to sustain GC develop-
ment (reviewed in Refs. 1 and 6).
Deciphering the factors that regulate the establishment
of an adequate population of mature SCs and thus testis
size remains one of the most critical questions in testicular
biology. FSH is considered one of the major endocrine
hormones regulating SC proliferation, with no synergistic
or additive effect from androgens (3, 4, 7, 8). The influ-
ence of several other paracrine factors and systemic hor-
mones (eg, thyroid hormones) in this process has also
been described (9–16).
Insulin and its related growth factors IGF1 and IGF2
can modulate a variety of cellular activities including cell
survival, stimulation of cell proliferation, differentiation,
and metabolism (17, 18). The physiological effects of
these factors are mediated through activation of 2 ty-
rosine kinase receptors: the insulin receptor (INSR) and
the type I insulin-like growth factor receptor (IGF1R).
Insulin and IGF1 bind primarily to INSR and IGF1R,
respectively, whereas IGF2 binds, with somewhat similar
affinities, to both receptors (19–21). Upon activation,
INSR and IGF1R phosphorylate common substrates that
activate a network of downstream effectors, including the
phosphatidylinositol 3-kinase (PI3K) and the mitogen-
activated protein kinase (MAPK) pathways, which are
both associated with proliferation, differentiation, and
cell survival (22, 23).
Several reports have shown that IGF1 regulates impor-
tant testicular functions such as testosterone production
by Leydig cells (LCs) (24). Unfortunately, little is known
about the local actions that the insulin-like family of
growth factors exert on GCs and SCs in vivo, because the
constitutive invalidation of their cognate receptors sys-
tematically leads to perinatal lethality. To overcome these
difficulties, we took advantage of the site specific Cre-lox
recombination system to delete Insr and/or Igf1r specifi-
cally in SCs or the GC lineage during testicular develop-
ment. By this means, we were able to demonstrate that the
insulin/IGF growth factor family is an essential compo-
nent of the endocrine and paracrine network that regu-
lates testis growth and sperm production in mammals.
Materials and Methods
Animals
Insrflox (Insrfx/fx), Igf1rflox (Igf1rfx/fx), and MisCre (Amh:
Cre) mice were provided by R. Kahn (Boston, Massachusetts),
A. Efstratiadis (New York, New York), and F. Guillou (Tours,
France), respectively, and were genotyped at weaning (P21)
from tail biopsies by classic PCR as described previously (25–
27). To analyze all different allelic inactivations, female mice
carrying both Insr and Igf1r floxed alleles (Insrfx/fx;Igf1rfx/fx)
were crossed with transgenic males expressing Cre-recombinase
under the control of the Mis promoter to generate 50% Insrfx/
wt;Igf1rfx/wt, and 50% Insrfx/wt;Igf1rfx/wt;Amh:Cre mice. These
animals were subsequently intercrossed to generate Sertoli-spe-
cific deletions of Insr (Insrfx/fx;Amh:Cre), Igf1r (Igf1rfx/fx;Amh:
Cre), or both Insr and Igf1r (Insrfx/fx;Igf1rfx/fx;Amh:Cre) as well
as control animals (Insrfx/fx;Igf1rfxfx or Insrfx/wt;Igf1rfx/wt;
Amh:Cre). Selective inactivation of Insr, Igf1r, or Insr;Igf1r in
male GCs was achieved using a similar strategy, taking advan-
tage of 2 GC-specific Cre lines: a Ngn3:Cre transgene (P.L.
Herrera, unpublished data) and a Mvh:Cre transgene (28). Both
GC-specific Cre transgenic lines were genotyped by classic PCR
using either Cre-recombinase–specific primers for theNgn3:Cre
transgene (20973, 5-CCTGTTTTGCACGTTCACCG-3;
20974, 5-ATGCTTCTGTCCGTTTGCCG-3) or a set of
primers specific for the Mvh;Cre transgene as described previ-
ously (28). Animals were housed and cared for according to the
ethical guidelines of the Direction Générale de la Santé of the
Canton de Genève (experimentation ID: 1061/3430/1).
Fertility tests and sperm analysis
Mice lacking mice lacking Insr, Igf1r, and both in SCs (SC-
Insr, SC-Igf1r, and SC-Insr;Igf1r, respectively) (n  3–4) or
control Insrfxfx;Igf1rfxfx males were each bred with 2 6-week-
old wild-type C57BL/6 female mice for a period of 6 months.
Number of litters and pups per litter were systematically re-
corded. The epididymal sperm count was performed with sperm
extracted from the caudal epididymis and ductus deferens of
adult (P180) male mice and was analyzed for its concentration
and viability as described previously (29–31). The testicular
sperm count was evaluated from testis by enumeration of ho-
mogenization-resistant spermatid and spermatozoa nuclei using
phase-contrast microscopy as described previously (32). In
short, adult testis (P180) from 6 controls and 6 SC-Insr;Igf1r
double-mutant mice were decapsulated and homogenized in a
blender for 45 seconds in 6 and 3 mL of H2O, respectively. After
2 rounds of sonication (12 kHz), an aliquot of the cell suspen-
sion was loaded on a Malassez hemocytometer and counted in
duplicate.
Sperm motility
For each individual mouse, epididymal sperm were diluted in
1 mL of M2 medium just before analysis. Then 5l of the sperm
suspension was deposited in a 20-m-deep counting chamber
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(Leja Products, Nieuw-Vennep, The Netherlands) and submit-
ted to computer-assisted sperm analysis (CASA) (SCA system;
Microptic SL, Barcelona, Spain). Five to 10 video sequences
were recorded (25 frames/s) at 37°C using a negative phase-
contrast 10 objective. The sperm motility parameters exam-
ined in this study were curvilinear velocity (VCL; micrometers
per second), straight-line velocity (VSL; micrometers per sec-
ond), average path velocity (VAP; micrometers per second), am-
plitude of lateral head displacement (ALH; micrometers), beat-
cross frequency (BCF; Hertz), linearity (LIN  VSL/VCL;
percent), straightness (STR  VSL/VAP; percent), and wobble
(WOB  VAP/VCL; percent). Motility was categorized as non-
progressive (VAP 15m/s), slow progressive (VAP 15 45
m/s), or fast progressive (VAP 45 m/s), as indicated by the
manufacturer’s instructions. The number of sperm present in the
initial 1-mL suspension was calculated by the CASA system (106
sperm cells/mL).
Histology and immunohistochemistry (IHC)
Testes and epididymides were fixed overnight either in 4%
paraformaldehyde (PFA) or in Bouin fixative and embedded in
paraffin. Sections (5-m) were stained with hematoxylin and
eosin (H&E) or processed for IHC. For IHC analysis, PFA-fixed
sections were incubated overnight at 4°C with the following
antibodies: anti-INSR (1:100, sc-711; Santa Cruz Biotechnol-
ogy, Santa Cruz, California), anti-IGF1R (1:50, sc-712; Santa
Cruz Biotechnology); anti-GATA4 (1:50, sc-9053; Santa-Cruz
Biotechnology), anti-p27Kip1 (1:100, K0082–3S; MBL, Na-
goya, Japan), anti-ZO1 (1:250, 61-7300; Zymed, South San
Francisco, California), anti-panAKT (1:200, ref. no. 9272; Cell
Signaling Technology, Danvers Massachusetts), anti-phospho-
AKT (1:250, ref. no. 9271; Cell Signaling Technology), anti-
smooth muscle actin (SMA) (1:100; gift from C. Chaponnier,
Department of Pathology and Immunology, University of Ge-
neva, Geneva, Switzerland), anti- galactosidase (1:500,
ab9361; Abcam, Cambridge, Massachusetts), anti-MVH (1:
1000; gift from Toshiaki Noce, Mitsubishi Kagaku of Life Sci-
ences, Tokyo, Japan), and anti-3-hydroxysteroid dehydroge-
nase (HSD) (1:500; gift from Ian Mason, Queen Margaret
University, Edinburg, United Kingdom). For fluorescent stain-
ing, Alexa-conjugated secondary antibodies (Invitrogen, Carls-
bad, California) were used for signal revelations, whereas for
stable staining, signals were revealed with 3,3-diaminobenzi-
dine (Sigma-Aldrich, Buchs, St-callen, Switzerland). All images
were obtained with a Axioskop microscope (Carl Zeiss, Jena
Germany) and processed using AxioVision software.
Proliferation and apoptosis assays
The proliferation assay was performed with PFA-fixed sec-
tions double stained with either anti-GATA4 (1:50, sc-9053;
Santa-Cruz Biotechnology) and anti-Ki-67 (1:100, no. 556003;
BD Biosciences, San Jose, California) overnight at 4°C or anti-
GATA4 combined with the Click-iT EdU cell proliferation assay
(Invitrogen) as described previously (33). A minimum of 3 dif-
ferent animals per genotype and developmental stage were an-
alyzed. For each testis, between 3 and 5 sections distant from
one another by at least 60 m were selected, and pictures of 5
different fields per section were taken. Values are expressed as
the percentage of proliferating SCs counted in a given region.
Apoptotic assays were performed by means of both a terminal
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)
reaction using an In Situ Cell Death Kit (Roche Applied Science,
Indianapolis, Indiana) and double IHC using anti-cleaved
caspase 3 (1:200, no. 9961L; Cell Signaling Technology) and
anti-GCNA1 (1:50; gift from Dr G.C. Enders, University of
Kansas Medical Center, Kansas City, Kansas) to reveal the iden-
tity of TUNEL-positive cells. The percentage of apoptotic,
TUNEL-positive cells within the seminiferous epithelium was
expressed as the average number of apoptotic cells within 20
seminiferous tubules.
Testis morphometry
Thirty transverse sections of seminiferous tubules from 3
different animals per genotype were randomly selected to mea-
sure small diameters. Diameters were measured in seminiferous
tubule sections that were round or close to being round. Mor-
phometric analysis was performed on a BX51 Olympus micro-
scope, and the image was captured using a JVC video camera.
Analysis was performed using the software package CAST Grid
(version 2.4.1, The Computer Assisted Stereological Toolbox;
Olympus, Tokyo, Japan). To obtain the volume density of sem-
iniferous tubules, the total number of tubules (round or near
round) was scored for each histological section, and an average
area of tubule was measured from at least 25 randomly selected
tubules. To obtain a more precise measure of testis volume,
shrinkage areas were excluded from the testis surface. Because
the specific gravity of testis tissue was considered to be 1.0, the
seminiferous tubule volume is determined as the product of the
volume density and testis weight. The total length of seminifer-
ous tubules (meters) was obtained by dividing seminiferous tu-
bule volume by the squared radius of the tubule times the 
value (34).
DNA content analysis by flow cytometry
For DNA content analysis, control and mutant testes were
dissected out, and GCs were isolated and stained with the inter-
calating agent propidium iodide (PI) as described previously
(62). In short, control and SC-Insr;Igf1r testes (n  5) at P180
were dissected out and decapsulated to release the seminiferous
tubules. The latter were incubated in collagenase type IV (Sig-
ma-Aldrich) at 37°C for up to 5 minutes under rapid agitation.
Dispersed tubules were allowed to settle down and were washed
twice with PBS without Ca2 and Mg2 (Sigma-Aldrich) to
remove the LCs and the peritubular myoid cells. Washed tubules
were then incubated for 5 minutes in 0.5% trypsin EDTA
(Gibco; Invitrogen) and RQ1/DNase (1 g/L; Promega, Mad-
ison, Wisconsin) at 37°C under agitation. A cell suspension was
obtained by pipetting gently several times before addition of 10
L of heat-inactivated fetal calf serum to block trypsin activity.
To generate a single-cell suspension, PBS without Ca2 and
Mg2 was added, and the preparation was filtered through a
40-m nylon cell strainer (BD Falcon; BD Biosciences Discovery
Labware, Bedford, Massachusetts). For nuclear analysis, GCs
were rinsed and resuspended in 1 mL of cold PI stain (10 mM
Tris, pH 8.0, 1 mM NaCl, 0.1% NP40, 50 g/mL PI, and 10
g/mL RNase A), vortexed for 2 to 3 seconds, and incubated on
ice for 10 minutes to both lyse the plasma membrane and stain
nuclear DNA. DNA content was assessed using a FACSCalibur
II (BD Biosciences).
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Isolation of total RNAs and proteins from purified
Sox9:GFP-positive SCs
Irfx/fx;Igf1rfx/fx;Mis:Cre and control mice were bred with
Sox9:EGFP knock-in mice to specifically label and sort SCs at
embryonic day (E) 15.5, E17.5, P0, P5, P10, P15, and P60 (35).
The introduction of an IRES-EGFP cassette into the 3-untrans-
lated region of the Sox9 gene does not affect Sox9 function
because both heterozygous and homozygous animals are viable
and fertile in contrast with Sox9 null heterozygous mice (36). At
relevant stages, control and SC-Insr;Igf1r male pups homozy-
gous for Sox9:EGFP were killed (n  5–10). Green fluorescent
protein (GFP)-positive testes were decapsulated and incubated
for 10 minutes in 0.5% trypsin EDTA and RQ1/DNase (4 mg/
mL) at 37°C. To ensure complete cellular dissociation, an addi-
tive digestive step was performed by incubating the cell clusters
in a solution/cocktail of collagenase (10 mg/mL), hyaluronidase
(20 mg/mL), and DNase (4 mg/mL). To generate a single-cell
suspension, PBS without Ca2 and Mg2 was added, and the
preparation was filtered through a 40-m nylon cell strainer
(BD Falcon; BD Biosciences Discovery Labware). GFP cells
were sorted using a FACSVantage SE (BD Biosciences). For
RNA extraction, GFP or GFP cells were directly sorted in
lysis buffer from an RNeasy kit and extracted using an RNeasy
micro kit (Qiagen, Valencia, California), according to the man-
ufacturer’s protocol. RNA integrity and quantity were assessed
using RNA 6000 picochips with a 2100 bioanalyzer (Agilent
Technologies, Santa Clara, California).
Classic and quantitative (q) real-time PCR
Between 120 and 1g of total RNAs was reverse-transcribed
with an Omniscript RT kit (Qiagen), according to the manufac-
turer’s instructions, and 1⁄20 of the cDNA template was used as
template for each PCR reaction. For regular RT-PCR amplifi-
cation, a classic 30-cycle program was used as described previ-
ously (37). Real-time RT-PCR was performed on each sample in
triplicate using an ABI 7900HT SDS system with Power SYBR
Green PCR Master Mix (Applied Biosystems, Foster City, Cal-
ifornia). Data were analyzed using a comparative critical thresh-
old (CT) method with the amount of target gene normalized to
the average of 3 endogenous control genes (cyclophilin B, tubu-
lin , and tubulin ). Normalized quantities were averaged for
at least 3 replicates for each data point and are presented as the
mean SD. The highest normalized relative quantity was arbi-
trarily designated as a value of 1.0. Fold changes were calculated
from the quotient of means of these normalized quantities and
are reported as the mean  SEM. The primers used for classic
and qRT-PCR are listed in Supplemental Table 1 published on
The Endocrine Society’s Journals Online web site at
http://mend.endojournals.org.
Hemicastration, FSH injection, and 6-propyl-2-
thiouracil (PTU) treatment
Newborn pups were either hemicastrated or sham-operated
at birth under hypothermia-induced anesthesia (38). A small
incision in the inguinal region was made, and the left testis was
removed (39). Groups of control or hemicastrated pups were
placed back with their mothers, and animals were killed at P60.
For FSH treatment, newborn control and mutant pups were
injected subcutaneously from birth (P0) to P10 with recombi-
nant human FSH (Gonal-F; Merck Serono) dissolved in physi-
ological solution (200 IU/kg in 0.9% NaCl) to induce SC pro-
liferation as described previously (40). Pups were subjected to
transient postnatal hypothyroidism by adding 0.1% PTU (Sig-
ma-Aldrich) to the drinking water between birth and P25 as
described previously (13). Then, pups were weaned, and tap
water was given ad libitum thereafter to allow recovery to eu-
thyroidism. Mice were killed at P60.
Human chorionic gonadotropin (hCG) stimulation
and hormonal assay
To evaluate the basal and hCG-stimulated serum concentra-
tions of testosterone, control and mutant animals were sub-
jected to an ip injection of hCG (Chorulon, 15 IU/animal).
Blood was collected from a retro-orbital sinus puncture before
the injection to determine basal levels. Two hours later, by the
time of killing, blood was collected by an intracardiac puncture.
Sera were obtained by centrifugation (8000 rpm, 10 minutes)
and conserved at20°C until hormone assays were performed.
FSH and LH levels were measured using an immunobeads Mil-
liplex magnetic kit as recommended by the supplier (Millipore
Corporation, Billerica, Massachusetts). Testosterone levels
were evaluated by RIA using a Testosterone Double Antibody
RIA Kit from MP Biomedicals (Solon, Ohio) and activin A using
an Activin A Quantikine ELISA Kit from R&D Systems (Min-
neapolis, Minnesota).
Results
Expression profile of Insr and Igf1r and their
ligands in SCs and male GCs
SCs provide a highly specialized environment crucial
for spermatogonia renewal and GC progression into sper-
matogenesis. To determine in which cells IGFs might play
a role in regulating testicular function, we analyzed by
qRT-PCR the expression of the insulin-like family of
growth factors and their receptors in purified GCs and
SCs at P5. At this stage, seminiferous tubules are exclu-
sively composed of proliferating, immature SCs (	84%)
and primitive type A spermatogonia (	16%) (41). Tak-
ing advantage of a Sox9-eGFP knock-in mouse line that
specifically labels SCs (35), we used fluorescence-acti-
vated cell sorting to isolate GFP and GFP cell fractions
from P5 testes. Both qRT-PCR and immunofluorescence
(IF) analyses confirmed that the GFP fraction was com-
posed of highly purified SCs (95% purity), whereas the
GFP fraction was composed mostly of GCs (	70%) and
Leydig cells (	30%) (Supplemental Figure 1, A–C). We
found that transcripts coding for the growth factors Igf1
and Igf2 were present at levels 	10-fold higher in the
spermatogonia-enriched GFP fraction than in the GFP
fraction (Figure 1A). In contrast, transcripts for Insr and
Igf1r were present at similar levels in immature SCs and
spermatogonia-enriched fractions. These expression pro-
files were confirmed by a large-scale transcriptional anal-
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ysis from a highly enriched population of mouse mature
SCs, mitotic spermatogonia, meiotic spermatocytes, and
postmeiotic round spermatids (42) (Supplemental Figure
1D). Overall, the robust expression of Igf1 and Igf2 in
male GCs and the presence of transcripts coding for Insr,
Igf1r, and the common effectors Irs1 and Irs2 in SCs and
GCs suggest that the insulin-like family of growth factors
exerts autocrine-paracrine actions within the seminifer-
ous epithelium.
Massive reduction in SC number, testis size, and
testicular sperm counts in mice lacking insulin/IGF
signaling in developing SCs
To investigate the functional relevance of insulin/IGF
signaling in both the GC and supporting cell lineages, we
specifically deleted Insr (43), Igf1r (26), or both Insr and
Igf1r either in the male germ line using a Ngn3:Cre trans-
genic line (44) or in SCs using anAmh:Cre transgene (27).
Despite the fact that the Ngn3:Cre transgene was able to
completely eliminate Insr and Igf1r in the male germ line,
mice with a GC-specific deletion of Insr, Igf1r, or both
Insr and Igf1r were viable and fertile (Supplemental Fig-
ure 2). All reproductive parameters were normal includ-
ing typical testicular histology, testis
size, and sperm production, indicat-
ing that the insulin/IGF signaling
pathway is dispensable for differen-
tiating male GCs throughout the
meiotic and postmeiotic stages of
spermatogenesis. We then examine
the in vivo role of insulin/IGF signal-
ing in SCs. For simplicity, SC-spe-
cific deletion of Insr (Insrfx/fx;Amh-
Cre), Igf1r (Igf1rfx/fx;AmhCre), or
both Insr and Igf1r (Insrfx/fx;Igf1rfx/
fx;AmhCre) is abbreviated as SC-
Insr, SC-Igf1r, and SC-Insr;Igf1r,
respectively. Similarly, control mice
bearing variable genotypes such as
Insrfx/fx, Igf1rfx/fx, Insrfx/fx;Igf1rfx/
fx, and Insrwt/fx;Igf1rwt/fx;AmhCre
are abbreviated as wt because of the
lack of phenotype (data not shown).
Amh-driven Cre recombinase has
been reported to efficiently delete
floxed alleles specifically in SCs
from E14.5 onward (27, 45). To as-
sess the efficiency of the Amh:Cre
transgene to eliminate specifically
and completely both Insr and Igf1r
transcripts in SCs, we crossed SC-
Insr;Igf1r mutant mice with the
Sox9:EGFP knock-in allele. We
show by qRT-PCR that Insr and Igf1r transcripts were
reduced by	90% in the GFP fractions of SC-Insr;Igf1r
mutants (Figure 1B). This residual expression correlated
well with the levels of GC contamination found in these
GFP fractions, suggesting that we achieved an efficient
and specific ablation of both receptors in SCs. These re-
sults were confirmed by IF, showing that signals for both
INSR and IGF1R were specifically absent in SCs of mu-
tant testis at P5 (Figure 1C).
SC-Insr, SC-Igf1r, and SC-Insr;Igf1r mutants were all
viable, grew to adulthood normally, and appeared to have
normal sexual behavior and normal internal and external
genitalia compared with those for control littermates. At
P180, testes lacking Insr, Igf1r, or both Insr and Igf1r in
SCs displayed weight reductions of 13.6%, 34.6%, and
72.4%, respectively, compared with those of their control
littermates (Figure 2, A–D and I, and Supplemental Table
2). Histological analysis of mutant testes revealed no
gross histological alteration of the seminiferous epithe-
lium, with the presence of GCs at all stages of spermato-
genesis and spermiogenesis (Figure 2, E–H). In contrast,
epididymal sperm concentrations in SC-Igf1r and SC-
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Figure 1. Expression profiles of Insr, Igf1r, and their ligands in purified gCs and SCs at P5. A,
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Insr;Igf1r mutants were decreased by 38.85% and
58.71%, respectively, compared with those in control an-
imals (Figure 2J and Supplemental Table 3). When the
focus was exclusively on the double SC-Insr;Igf1r mu-
tants, testicular sperm concentration, a reflection of daily
sperm production, was also drastically reduced by 79%
(Figure 2K). At this stage, neither the seminiferous epithe-
lium architecture, the seminiferous tubule diameter, nor
the SC number per tubule section was affected (Supple-
mental Figure 3, A–F). However, we observed a massive
75% reduction in tubule length (wt, 1.86  0.1 m; SC-
Insr;Igf1r, 0.42  0.17 m; P  .0002) (Figure 2L), cor-
relating well with a 74.3% reduction in the total number
of SCs in SC-Insr;Igf1r mutant testes (Figure 2M).
Although sperm output was drastically reduced, sperm
viability (Figure 2N) and sperm motility behavior were
normal in SC-Insr, SC-Igf1r, and double SC-Insr;Igf1r
mutant animals as measured by CASA (Supplemental Ta-
ble 4). Because a reduction in sperm concentration could
affect male reproductive function, we mated SC-Insr, SC-
Igf1r, and double SC-Insr;Igf1r mutant males with 2
C57BL/6 female mice for a period of 6 months. Frequencies
of parturition and litter size were not affected, indicating
that loss of function of Insr, Igf1r, or both Insr;Igf1r in SCs
does not impair reproductive ability despite oligospermia
(Figure 2, O and P). Taken together, these results demon-
strate that the massive reductions in testis size, tubule length,
and sperm output in mutant animals is a consequence of a
proportional reduction in the number of SCs.
Reduced SC proliferation in SC-Insr;Igf1r mice
during late fetal and early neonatal testicular
development
The establishment of an adequate number of SCs in the
adult testis depends on the duration of the proliferative
phase and the rate of division. We took advantage of the
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Sox9;EGFP knock-in allele described previously to eval-
uate the progression in testis weight and SC numbers in
both wt and SC-Insr;Igf1r mutant testes during late fetal
and early neonatal testicular development. Whereas the
first abnormalities in terms of testis weight appeared at P5
(Figure 3A), we observed a progressive and cumulative
reduction of SC number in mutant animals during the late
fetal and early neonatal stages of development (Figure
3B). At E17.5, about 3 to 4 days after the onset of Amh;
Cre transgene expression, we already noticed a 40% re-
duction in SC number. This deficit in SCs worsened at
later stages, reaching 43% at P0, 60% at P5, 67% at P15,
and finally 74.3% at P60 (Figure 2M). A more refined
analysis revealed that the daily rate of increase in SC
number was primarily affected around E17.5 (54%)
and during the P0 to P5 period (38%) (Figure 3C). This
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dramatic reduction in testis size and total SC numbers
during the late fetal/neonatal period led us to the assump-
tion that the balance between cell proliferation and death
had been perturbed in SCs lacking the insulin/IGF signal-
ing pathway. As evidenced by double anti-GATA4/anti-
Ki-67 IHC, SC proliferation rates were indeed reduced at
2 specific stages of development: by 66% at E17.5 and by
8% at P5 in SC-Insr;Igf1r testes compared with control
testes (Figure 3, D–H). These results were confirmed by
combining anti-GATA4 IF with the Click-iT EdU cell pro-
liferation assay (Supplemental Figure 4). In contrast, ap-
optosis in SCs was unaffected (data not shown). These
findings suggest that the striking testis size reduction ob-
served in SC-Insr;Igf1r mice is a di-
rect consequence of a reduced pro-
liferation rate of immature SCs
during the late fetal and early neo-
natal testicular period.
Transient delay in SC
maturation and
desynchronization of
spermatogenesis in
seminiferous tubules of SC-Insr;
Igf1r testes
At E17.5 (data not shown) and
birth (P0), double mutant testes dis-
played normal organization of the
seminiferous epithelium and were
histologically indistinguishable
from controls (Figure 4, A and E).
The first histological abnormalities
appeared at P5 with spermatogonia
being mislocalized in a central posi-
tion instead of lying against the
basement membrane (arrows in Fig-
ure 4F). We also observed 2- and 6-
fold increases in the number of apo-
ptotic GCs in P3 and P5 mutant tes-
tes compared with control testes
(data not shown), correlating with
the reduced number of SCs and the
first histological abnormalities. At
P10, we detected numerous py-
knotic cells (white arrowheads)
within testis cords and a hyperplasia
of the interstitial tissue (Figure 4G).
By P15, no lumen was observed in
mutant seminiferous tubules, prob-
ably due to absence of seminiferous
tubular fluid secretion (46) resulting
from a delay in SC maturation (Fig-
ure 4H). In addition, several aspects
of SC morphology suggested that these cells had remained
in an immature state, because the nucleus did not reach a
normal peripheral localization and strongly differed from
the triangular shape characteristic of this developmental
stage (Figure 4, D and H). We also observed vacuoles
within tubules, a typical sign of GC sloughing. Delay in
SC maturation was also investigated by immunohisto-
chemical localization of protein markers associated with
SC maturity such as p27, a marker of terminal differen-
tiation, and Z01, a tight junction–associated protein es-
sential for the blood-testis barrier (Figure 4, Q–Z). At
P21, the few lumen that appeared late within the tubules
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of SC-Insr;Igf1r testes displayed a smaller diameter than
those found in control tubules (Figure 4M). However,
spermatogenesis was normal in P21 mutant testes with
the appearance of the first round spermatids. Finally, at
P42, the first wave of GC meiosis was normally achieved
in both control and double mutant testes, and all stages of
differentiating GCs were present within the seminiferous
tubules. Interestingly, we noticed that the seminiferous
epithelium cycle is desynchronized in some SC-Insr;Igf1r
seminiferous tubes, with individual sections having atyp-
ical GC associations containing step 1 round spermatids
(black arrow) with step 8 elongated spermatids (white
arrow) (Figure 4, L–P). These kinds of discrepancies were
not observed in P180 mutant testis, indicating a transitory
alteration of GC differentiation (Supplemental Figure 5).
These data show that SC maturation is delayed in SC-
Insr;Igf1r testes, resulting in a desynchronized progres-
sion of GCs during the first wave of spermatogenesis.
Morphology and function of Leydig cells and
peritubular myoid cells were not affected in SC-
Insr;Igf1r mutant testes
In addition to regulating spermatogenesis, SCs are also
required to promote differentiation of both peritubular
myoid cells (PMCs) and LCs (47). To investigate to what
extent the numbers of PMCs and LCs were affected in
SC-Insr;Igf1r, we performed IF assays using specific
markers for both cell types. Using an antibody for SMA,
we found that PMCs were not affected in terms of mor-
phology, number/tubule, and localization in mutant testis
(Figure 5A, B, and E). These results imply that the total
number of PMCs present in the mutant testis is reduced to
the proportion of the remaining SCs/seminiferous tu-
bules. Using an anti-3HSD to evaluate LC population,
we found that the proportion of LCs present in the inter-
stitial compartment was slightly increased in mutant tes-
tes (68% vs 61% in control) (Figure 5, C, D, and F). LC
function was also evaluated by assessing the plasma levels
of testosterone before (basal) and 2 hours after an ip
injection of hCG (stimulated level). Although androgen
levels in the basal state were not significantly affected,
increased testosterone production by hCG was not as
high as that in control animals (3.03-fold in mutant vs
7.69-fold in control animals) (Figure 5G). Interestingly,
LH and activin levels were not affected, whereas FSH
levels were 2.5-fold higher in mutant animals than in con-
trol mice (Figure 5, H–J). Overall, these results show that
total numbers of LCs and PMCs are reduced at levels
proportional to the number of SCs present in mutant tes-
tes. However, LC endocrine function was not signifi-
cantly affected because basal testosterone levels were
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comparable and high enough to sustain normal spermato-
genesis in mutant individuals.
Insulin/IGF signaling acts independently of thyroid
hormones but is essential for FSH-mediated SC
proliferation
The establishment of an adequate number of SCs in the
adult testis depends on the duration of the proliferative
phase and the rate of division. In
mice, SCs proliferate from E12.5
through P10 (13), and both thyroid
hormones and FSH are critical pri-
mary regulators of neonatal SC pro-
liferation and functional matura-
tion. The massive reduction in the
total number of SCs in mutant testes
(ie, 74%) raises the possibility that
the insulin/IGF signaling pathway
may be required either for T3 or
FSH action on neonatal SC prolifer-
ation and maturation.
To study the potential interaction
between T3 and the insulin/IGF sig-
naling pathway, we induced tran-
sient hypothyroidism during early
postnatal development by adding
the goitrogen PTU (0.1%) to the wa-
ter from birth to P25 either in wt or
SC-Insr;Igf1r mutant males (Figure
6, A–C). In P60 wt animals exposed
to PTU, the relative testis weight and
testicular reserves were both sub-
stantially increased by 150% and
149%, respectively, as reported pre-
viously (13). Interestingly, in SC-
Insr;Igf1rmutant mice, we observed
a similar increase in relative testis
weight and testicular sperm reserve
after neonatal PTU treatment. This
increase in testis weight and func-
tion was accompanied by a 154%
increase in seminiferous tubule
length, indicating that hypothyroid-
ism increases SC number in the ab-
sence of the insulin/IGF signaling
pathway. These findings reveal that
T3 and insulin/IGFs act indepen-
dently to modulate the number of
SCs through different pathways and
mechanisms.
In parallel, we used a model of
neonatal hemicastration (38) to in-
vestigate the potential interaction
between FSH and the insulin/IGF signaling pathway.
Neonatal removal of a single gonad results in a significant
increase in serum FSH concentration and a subsequent
increase in the number of SCs as well as the size and the
sperm production from the remaining testis (38, 39).
Whereas testis size and epididymal sperm counts were
increased by 142% and 134%, respectively, in hemicas-
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trated control males, no effects on testicular function
were observed in hemicastrated SC-Insr;Igf1r mutant
mice. More precisely, testis weight, epididymal sperm
count, and seminiferous tubule length were not affected
by hemicastration and the subsequent increase in FSH
levels in SC-Insr;Igf1r mutant mice (Figure 6, D–F). To
confirm the key role played by the insulin/IGF signaling
pathway in mediating FSH proliferative action on imma-
ture SCs, we treated newborn control and SC-Insr;Igf1r
mutant mice between birth (P0) and P10 with recombi-
nant human FSH at a concentration known to promote
SC proliferation and testicular growth in rats (40). As
expected, we found that testis size was significantly in-
creased by 20% and 40% in control animals at P21 and
P60, respectively. At P60, sperm output was also in-
creased by 43% in controls (Figure 6H). In contrast, nei-
ther testis weight nor epididymal sperm counts were af-
fected by FSH treatment in SC-Insr;Igf1r mutants
compared with those in controls (Figure 6, G and H).
Overall, these results indicate unambiguously that neona-
tal action of FSH requires the insulin/IGF signaling path-
way to mediate its proliferative effects on immature SCs.
Both Fshr gene expression profile and AKT
activation were affected in SCs lacking tINSR and
IGF1R
In mutant animals, high FSH levels (Figure 5J) coupled
with the inability to respond to FSH (Figure 6, D–H)
suggest that FSH signaling may be affected in immature
SCs lacking insulin/IGF signaling. Using qRT-PCR, we
found in mutant purified SCs that transcript levels coding
for the FSH receptor (FSHR) were reduced both at P5 and
P15 by 26% and 37%, respectively (Figure 6P). In a sim-
ilar manner, we found that inhibin B expression was also
reduced in purified mutant SCs specifically at P0 and P5
(Figure 6J). In contrast, the expression of housekeeping
genes as well as Amh was not affected, suggesting a spe-
cific alteration (data not shown). The reduced FSHR ex-
pression observed in mutant SCs should have a negative
impact on FSH action and explain in part the incapacity
of SCs lacking insulin/IGF signaling to proliferate after
hemicastration or FSH treatment during the neonatal
period.
Next we examined the expression and activation of
protein kinase B/AKT, a signaling molecule that is part of
the PI3K/AKT pathways known to be activated by both
FSH and/or IGFs exposure in SCs and granulosa cells (48,
49). In control testes, we found by IF that AKT and its
phosphorylated form were present at high levels specifi-
cally at P5 in the center of the testis cords, a region that
corresponds to the cytoplasm of SCs (Figure 6, J–L). In
contrast, we observed that immature SCs of mutant testes
at P5 were almost devoid of AKT signal (Figure 6, M–O),
suggesting that the PI3K/AKT signaling pathway is not
functional in immature SCs around P5.
Discussion
The major objectives of this study were to investigate the
potential roles of the insulin-like family of growth factors
on testis development and spermatogenesis. By deleting
Insr and/or Igf1r either in GCs or in SCs, we provide in
vivo evidence that the insulin receptor family is dispens-
able in the GC lineage but plays a major role in regulating
immature SC proliferation and maturation and ultimately
the total pool of adult SCs. Compared with single recep-
tor mutant mice, we observed a more severe reduction in
total SC number and testis size in mice lacking both Insr
and Igf1r, revealing a novel concerted action of both
INSR and IGF1R in testicular development. In addition,
both in vivo and in vitro analyses revealed that FSH re-
quires the insulin/IGF signaling pathway to mediate its
proliferative effects on immature SCs. Our data reinforce
the view that the local production of insulin/IGF growth
factors is the major intratesticular signal regulating SC
number, testis size, and sperm output in mammals.
Although several factors play a role in the proliferation
and maturation of SCs (50), insulin/IGF signaling is likely
to represent the major hormonal signal involved in the
establishment of a normal-sized cohort of SCs. When the
influence of known factors affecting SC numbers such as
FSH, androgens, or thyroid hormones are compared, our
data indicate that the insulin signaling pathway is quan-
titatively the most important pathway regulating the final
pool of SCs. In mice lacking the FSH receptor specifically
in SCs (FSHRKO), the reduction in testis weight and SC
number was approximately 55% to 60% (7) compared
with 70% for SC-Insr;Igf1r mice. Similarly, transient
neonatal hyperthyroidism resulted in a 50% reduction in
the final SC number at P23 due to direct suppression of
SC proliferation while their maturation is promoted (51)
In contrast, androgens do not appear to have a direct
effect on SC proliferation. Although androgens were ini-
tially shown to regulate SC proliferation in androgen-
resistant tfm mice (52), the pool of adult SCs was not
affected in mice lacking the androgen receptor specifically
in the SC (SCARKO) (7), indicating that the androgen-
dependent regulation of SC number is an indirect effect of
androgen on the SC.
Interconnected actions of both FSH and IGF1 in
regulating SC proliferation and function
The insulin/IGF family of growth factors acts mainly
through INSR and IGF1R and activates 2 major signaling
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pathways, namely the extracellular signal–regulated ki-
nase/MAPK pathway and the PI3K/AKT pathway, both
of which are important mediators of proliferation and cell
survival. Although the FSHR belongs to the superfamily
of G protein–coupled receptors, both the MAPK and
PI3K/AKT pathways are also activated upon FSH binding
to its receptor (for review, see 53), suggesting that FSH
and IGF actions may be intricately interconnected and
coordinated in SCs.
First, it has been shown that FSH is capable of stimu-
lating the secretion of IGF1 by immature SCs (54–56). In
addition, FSH has been shown to amplify IGF1-mediated
PI3K/AKT signaling in SCs. These results provide evi-
dence that FSH interacts with the IGF pathways at differ-
ent levels to stimulate the secretion of IGF1 by SCs and
also enhances its effects on PI3K/AKT signaling (48). Our
in vivo results demonstrate that both INSR and IGF1R
are required for FSH-mediated SC proliferation. How-
ever, the precise mechanism explaining how the insulin/
IGF signaling pathway is required for FSH action in im-
mature SCs is only starting to be unraveled. IGFs could
act at several levels by stimulating either the expression of
the FSHR and/or the activation of downstream signaling
pathways common to both IGFs and FSH. Our expres-
sion analysis revealed first that Fshr transcripts were re-
duced in purified SCs lacking insulin/IGF signaling but
only at P5 and P15 and not at earlier stages (Figure 6P).
This reduction may affect FSH action and explain in part
the incapacity of mutant SCs to proliferate after hemicas-
tration or FSH treatment. Second, we also found that
both INSR and IGF1R are required for AKT expression
and activation in SCs at P5 (Figure 6, J-O) suggesting that
AKT mediates the synergistic effect of FSH and IGFs on
SC proliferation. Similar interactions between the IGF
system and FSH have been reported in granulosa cells.
Fshr expression and mRNA stability are increased by
IGF-1 treatment in rat granulosa cells (57). In addition, it
has been recently reported that IGFIR activity is essential
for FSH-induced phosphorylation of AKT (49). Rat gran-
ulosa cells treated with a IGF1R inhibitor abolished AKT
activation by FSH and prevented expression of steroido-
genic genes and estradiol production. Taken together,
these results obtained in both granulosa cells and SCs
suggest a crucial role for IGFs in mediating FSH action in
the gonads.
Insulin/IGF signaling in SCs is not essential for
spermatogenesis and sperm production
The major role of SCs in the adult testis is to support
GCs and secrete factors that control the survival and pro-
gression of GCs through the sequential steps of spermato-
genesis. Based on in vitro studies suggesting that IGF1
regulates several functions of the mature SC (48, 58), we
would have expected that ablation of insulin/IGF signal-
ing in adult SCs or GCs would cause detrimental conse-
quences for sperm production and mouse fertility. Sur-
prisingly, this was not the case. First, ablation of both Insr
and Igf1r in the GC lineage did not reveal alterations in
sperm production and fertility (see Supplemental Figure
2). Second, although conditional deletion of Insr and
Igf1r in SCs reduced drastically the final number of SCs
by decreasing the survival rate and delaying differentia-
tion of immature SCs, the capacity of adult SCs to support
spermatogenesis is only mildly affected. A precise assess-
ment of spermatogenesis in SC-Insr;Igf1r mutant mice at
P60 revealed a small but significant decrease in the effi-
ciency of sperm production. Using flow cytometry of PI-
labeled cells to evaluate the abundance of haploid (1n;
spermatids and spermatozoa), diploid (2n; spermatogo-
nia A and B), and tetraploid cells (4n; spermatocytes I) in
P60 adult animals, we found a decrease in the proportion
of haploid cells in SC-Insr;Igf1r mutant testes (Supple-
mental Figure 6, A–C). Interestingly, the expression of
some Sertoli-specific genes such as inhibin  and Steel
(KitL) was significantly higher in SC-Insr;Igf1r testes,
whereas other transcripts coding for Amh, Gata1, trans-
ferrin, Pem, and testin were not affected (Supplemental
Figure 6D). Because inhibin is known to be stimulated by
FSH, we also assessed gonadotropin and androgen levels
in SC-Insr;Igf1r mutant mice. Although plasma levels of
LH and activin were unaffected, we observed a significant
2.5-fold increase in FSH levels of SC-Insr;Igf1r mutant
mice (Figure 5, G–J). Importantly, we observed signifi-
cant 7.7- and 3-fold increase in testosterone levels of con-
trol and SC-Insr;Igf1r mutant mice after hCG stimula-
tion, indicating normal although blunted androgen
production by Leydig cells. These findings indicate that
growth factors of the insulin family are key to regulating
the final number of SCs and testis size but dispensable for
SCs to support the spermatogenic process.
Receptor contribution
Comparative analysis of mutant animals lacking Insr,
Igf1r, or both Insr and Igf1r in SCs provided information
concerning the relative degree of contribution and func-
tional redundancy of each receptor in regulating SC num-
ber and testis size. Testes lacking Insr or Igf1r in SCs
displayed weight reductions of 13.6% and 34.6%, re-
spectively, indicating that the contribution of IGF1R is
more important than INSR. In addition, the concomitant
ablation of both receptors resulted in a much more severe
reduction in testis weight (72.4%), implying an important
redundancy and suggesting that INSR and IGF1R act in a
synergistic manner to regulate SC number and testis size.
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Taking into account both the ligand-binding affinities
and the relative contribution of INSR and IGF1R to the
phenotype, we can obtain some important information
concerning the identity of the potential ligand(s) mediat-
ing SC survival in the developing testis. The affinity of
insulin for IGF1R has been reported to be 500 to 1000
times lower than that of the IGFs (59). IGF2 binds to its
cognate receptor (IGF1R) and also to one of the insulin
receptor isoforms (IR-A), exhibiting an affinity that is
	30% that of insulin (21, 60). Finally, IGF1 binds IGF1R
with up to 20-fold higher affinity than IGF2 (61). The
robust expression of IGF1 and IGF2 in spermatogonia
(see Figure 1 and Supplemental Figure 1) raises the hy-
pothesis that GCs themselves may finely regulate the
number of SCs and thus testis size and daily sperm output,
through the secretion of growth factors promoting SC
survival and maturation during postnatal testicular devel-
opment. Clearly further investigations are required to test
this hypothesis.
Acknowledgments
Address all correspondence and requests for reprints to: Serge
Nef, Department of Genetic Medicine and Development, Uni-
versity of Geneva Medical School, 1, rue Michel-Servet, CH
1211 Geneva 4, Switzerland. E-mail: serge.nef@unige.ch.
This work was supported by National Centers of Compe-
tence in Research Frontiers in Genetics and by the Département
de l’Instruction Publique of the State of Geneva.
Author contributions include the following: S.N. and J.-L.P
conceived and designed the experiments. J.-L.P., P.C., C.Z.,
B.C., M.D.P., F.A., C.C., F.U., B.F., M.C., and M.D. performed
the experiments. S.N., J.-L.P., and P.C. analyzed the data.
P.L.H., F.P., M.G., F.G., and B.J. contributed reagents/materi-
als/analysis tools. S.N., J.-L.P., and P.C. wrote the manuscript.
Disclosure Summary: The authors have nothing to disclose.
References
1. Jégou B. The Sertoli cell. Baillieres Clin. Endocrinol. Metab. 1992;
6:273–311.
2. Mruk DD, Cheng CY. Sertoli-Sertoli and Sertoli-germ cell interac-
tions and their significance in germ cell movement in the seminifer-
ous epithelium during spermatogenesis. Endocr Rev. 2004;25:747–
806.
3. Orth JM, Gunsalus GL, Lamperti AA. Evidence from Sertoli cell-
depleted rats indicates that spermatid number in adults depends on
numbers of Sertoli cells produced during perinatal development.
Endocrinology. 1988;122:787–794.
4. Baker PJ, O’Shaughnessy PJ. Role of gonadotrophins in regulating
numbers of Leydig and Sertoli cells during fetal and postnatal de-
velopment in mice. Reproduction. 2001;122:227–234.
5. Vergouwen RP, Jacobs SG, Huiskamp R, Davids JA, de Rooij DG.
Proliferative activity of gonocytes, Sertoli cells and interstitial cells
during testicular development in mice. J Reprod Fertil. 1991;93:
233–243.
6. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. Proliferation and
functional maturation of Sertoli cells, and their relevance to disor-
ders of testis function in adulthood. Reproduction. 2003;125:769–
784.
7. Abel MH, Baker PJ, Charlton HM, et al. Spermatogenesis and
Sertoli cell activity in mice lacking Sertoli cell receptors for follicle-
stimulating hormone and androgen. Endocrinology. 2008;149:
3279–3285.
8. Marshall GR, Plant TM. Puberty occurring either spontaneously or
induced precociously in rhesus monkey (Macaca mulatta) is associ-
ated with a marked proliferation of Sertoli cells.Biol Reprod. 1996;
54:1192–1199.
9. Bagheri-Fam S, Argentaro A, Svingen T, et al. Defective survival of
proliferating Sertoli cells and androgen receptor function in a mouse
model of the ATR-X syndrome. Hum Mol Genet. 2011;20:2213–
2224.
10. Boitani C, Stefanini M, Fragale A, Morena AR. Activin stimulates
Sertoli cell proliferation in a defined period of rat testis develop-
ment. Endocrinology. 1995;136:5438–5444.
11. Hu J, Shima H, Nakagawa H. Glial cell line-derived neurotropic
factor stimulates Sertoli cell proliferation in the early postnatal
period of rat testis development. Endocrinology. 1999;140:3416–
3421.
12. Jaillard C, Chatelain PG, Saez JM. In vitro regulation of pig Sertoli
cell growth and function: effects of fibroblast growth factor and
somatomedin-C. Biol Reprod. 1987;37:665–674.
13. Joyce KL, Porcelli J, Cooke PS. Neonatal goitrogen treatment in-
creases adult testis size and sperm production in the mouse. J An-
drol. 1993;14:448–455.
14. Petersen C, Boitani C, Fröysa B, Soder O. Transforming growth
factor- stimulates proliferation of rat Sertoli cells. Mol Cell Endo-
crinol. 2001;181:221–227.
15. Petersen C, Boitani C, Fröysa B, Söder O. Interleukin-1 is a potent
growth factor for immature rat Sertoli cells. Mol Cell Endocrinol.
2002;186:37–47.
16. Fumel B, Guerquin MJ, Livera G, et al. Thyroid hormone limits
postnatal Sertoli cell proliferation in vivo by activation of its 1
isoform receptor (TR1) present in these cells and by regulation of
Cdk4/JunD/cmyc mRNA levels in mice. Biol Reprod 2012;87:16,
1–9
17. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol. 1998;42:
955–976.
18. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of
insulin and IGF-I receptors. Endocr Rev. 2001;22:818–835.
19. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like
growth factors in embryonic and postnatal growth. Cell. 1993;75:
73–82.
20. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice
carrying null mutations of the genes encoding insulin-like growth
factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75:59–
72.
21. Louvi A, Accili D, Efstratiadis A. Growth-promoting interaction of
IGF-II with the insulin receptor during mouse embryonic develop-
ment. Dev Biol. 1997;189:33–48.
22. Avruch J. Insulin signal transduction through protein kinase cas-
cades. Mol Cell Biochem. 1998;182:31–48.
23. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling
pathways: insights into insulin action.Nat RevMol Cell Biol. 2006;
7:85–96.
24. Baker J, Hardy MP, Zhou J, et al. Effects of an Igf1 gene null
mutation on mouse reproduction. Mol Endocrinol. 1996;10:903–
918.
25. Brüning JC, Gautam D, Burks DJ, et al. Role of brain insulin re-
ceptor in control of body weight and reproduction. Science. 2000;
289:2122–2125.
826 Pitetti et al IGFs, Sertoli Cells, and Testis Size Mol Endocrinol, May 2013, 27(5):814–827
26. Dietrich P, Dragatsis I, Xuan S, Zeitlin S, Efstratiadis A. Condi-
tional mutagenesis in mice with heat shock promoter-driven cre
transgenes. Mamm Genome. 2000;11:196–205.
27. Lécureuil C, Fontaine I, Crepieux P, Guillou F. Sertoli and granu-
losa cell-specific Cre recombinase activity in transgenic mice. Gen-
esis. 2002;33:114–118.
28. Gallardo T, Shirley L, John GB, Castrillon DH. Generation of a
germ cell-specific mouse transgenic Cre line, Vasa-Cre. Genesis.
2007;45:413–417.
29. Guerif F, Cadoret V, Plat M, et al. Characterization of the fertility
of Kit haplodeficient male mice. Int J Androl. 2002;25:358–368.
30. Surace EI, Strickland A, Hess RA, Gutmann DH, Naughton CK.
Tslc1 (nectin-like molecule-2) is essential for spermatozoa motility
and male fertility. J Androl. 2006;27:816–825.
31. Touré A, Lhuillier P, Gossen JA, et al. The testis anion transporter
1 (Slc26a8) is required for sperm terminal differentiation and male
fertility in the mouse. Hum Mol Genet. 2007;16:1783–1793.
32. Jégou B, Velez de la Calle JF, Bauché F. Protective effect of me-
droxyprogesterone acetate plus testosterone against radiation-in-
duced damage to the reproductive function of male rats and their
offspring. Proc Natl Acad Sci USA. 1991;88:8710–8714.
33. Salic A, Mitchison TJ. A chemical method for fast and sensitive
detection of DNA synthesis in vivo. Proc Natl Acad Sci USA. 2008;
105:2415–2420.
34. Franc¸a LR, Godinho CL.Testis morphometry, seminiferous epithe-
lium cycle length, and daily sperm production in domestic cats (Felis
catus). Biol Reprod. 2003;68:1554–1561.
35. Nel-Themaat L, Vadakkan TJ, Wang Y, Dickinson ME, Akiyama
H, Behringer RR. Morphometric analysis of testis cord formation
in Sox9-EGFP mice. Dev Dyn. 2009;238:1100–1110.
36. Bi W, Huang W, Whitworth DJ, et al. Haploinsufficiency of Sox9
results in defective cartilage primordia and premature skeletal min-
eralization. Proc Natl Acad Sci USA. 2001;98:6698–6703.
37. Nef S, Schaad O, Stallings NR, et al. Gene expression during sex
determination reveals a robust female genetic program at the onset
of ovarian development. Dev Biol. 2005;287:361–377.
38. Orth JM, Higginbotham CA, Salisbury RL. Hemicastration causes
and testosterone prevents enhanced uptake of [3H] thymidine by
Sertoli cells in testes of immature rats. Biol Reprod. 1984;30:263–
270.
39. Simorangkir DR, de Kretser DM, Wreford NG. Increased numbers
of Sertoli and germ cells in adult rat testes induced by synergistic
action of transient neonatal hypothyroidism and neonatal hemicas-
tration. J Reprod Fertil. 1995;104:207–213.
40. Nurmio M, Kallio J, Adam M, Mayerhofer A, Toppari J, Jahnu-
kainen K. Peritubular myoid cells have a role in postnatal testicular
growth. Spermatogenesis. 2012;2:79–87.
41. Bellvé AR, Cavicchia JC,Millette CF, O’Brien DA, Bhatnagar YM,
DymM. Spermatogenic cells of the prepuberal mouse. Isolation and
morphological characterization. J Cell Biol. 1977;74:68–85.
42. Chalmel F, Rolland AD, Niederhauser-Wiederkehr C, et al. The
conserved transcriptome in human and rodent male gametogenesis.
Proc Natl Acad Sci USA. 2007;104:8346–8351.
43. Brüning JC, Michael MD, Winnay JN, et al. A muscle-specific in-
sulin receptor knockout exhibits features of the metabolic syn-
drome of NIDDM without altering glucose tolerance. Mol Cell.
1998;2:559–569.
44. Korhonen HM, Meikar O, Yadav RP, et al. Dicer is required for
haploid male germ cell differentiation in mice. PLoS One. 2011;6:
e24821.
45. PapaioannouMD, Pitetti JL, Ro S, et al. Sertoli cell Dicer is essential
for spermatogenesis in mice. Dev Biol. 2009;326:250–259.
46. Rato L, Socorro S, Cavaco JE, Oliveira PF. Tubular fluid secretion
in the seminiferous epithelium: ion transporters and aquaporins in
Sertoli cells. J Membr Biol. 2010;236:215–224.
47. Yao HH, Whoriskey W, Capel B. Desert Hedgehog/Patched 1 sig-
naling specifies fetal Leydig cell fate in testis organogenesis. Genes
Dev. 2002;16:1433–1440.
48. Khan SA, Ndjountche L, Pratchard L, Spicer LJ, Davis JS. Follicle-
stimulating hormone amplifies insulin-like growth factor I-medi-
ated activation of AKT/protein kinase B signaling in immature rat
Sertoli cells. Endocrinology. 2002;143:2259–2267.
49. Zhou P, Baumgarten SC,WuY, et al. IGF-I signaling is essential for
FSH stimulation of AKT and steroidogenic genes in granulosa cells.
Mol Endocrinol. 2013;27:511–523.
50. Mackay S, Smith RA. Effects of growth factors on testicular mor-
phogenesis. Int Rev Cytol. 2007;260:113–173.
51. van Haaster LH, de Jong FH, Docter R, de Rooij DG. High neona-
tal triiodothyronine levels reduce the period of Sertoli cell prolifer-
ation and accelerate tubular lumen formation in the rat testis, and
increase serum inhibin levels. Endocrinology. 1993;133:755–760.
52. Johnston H, Baker PJ, Abel M, et al. Regulation of Sertoli cell
number and activity by follicle-stimulating hormone and androgen
during postnatal development in the mouse. Endocrinology. 2004;
145:318–329.
53. Walker WH, Cheng J. FSH and testosterone signaling in Sertoli
cells. Reproduction. 2005;130:15–28.
54. Cailleau J, Vermeire S, Verhoeven G. Independent control of the
production of insulin-like growth factor I and its binding protein by
cultured testicular cells. Mol Cell Endocrinol. 1990;69:79–89.
55. Chatelain P, Naville D, Avallet O, et al. Paracrine and autocrine
regulation of insulin-like growth factor I. Acta Paediatr Scand
Suppl. 1991;372:92–95; discussion 96.
56. Palmero S, Prati M, Barreca A, Minuto F, Giordano G, Fugassa E.
Thyroid hormone stimulates the production of insulin-like growth
factor I (IGF-I) by immature rat Sertoli cells. Mol Cell Endocrinol.
1990;68:61–65.
57. Minegishi T, Hirakawa T, Kishi H, et al. A role of insulin-like
growth factor I for follicle-stimulating hormone receptor expres-
sion in rat granulosa cells. Biol Reprod. 2000;62:325–333.
58. Froment P, Vigier M, Nègre D, et al. Inactivation of the IGF-I
receptor gene in primary Sertoli cells highlights the autocrine effects
of IGF-I. J Endocrinol. 2007;194:557–568.
59. De Meyts P, Wallach B, Christoffersen CT, et al. The insulin-like
growth factor-I receptor. Structure, ligand-binding mechanism and
signal transduction. Horm Res. 1994;42:152–169.
60. Frasca F, Pandini G, Scalia P, et al. Insulin receptor isoform A, a
newly recognized, high-affinity insulin-like growth factor II recep-
tor in fetal and cancer cells. Mol Cell Biol. 1999;19:3278–3288.
61. Germain-Lee EL, Janicot M, Lammers R, Ullrich A, Casella SJ.
Expression of a type I insulin-like growth factor receptor with low
affinity for insulin-like growth factor II. Biochem J. 1992;281(Pt
2):413–417.
62. Cederroth CR, Zimmermann C, Beny JL, et al. Potential detrimen-
tal effects of a phytoestrogen-rich diet on male fertility in mice. Mol
Cell Endocrinol. 2010;321(2):152–160.
doi: 10.1210/me.2012-1258 mend.endojournals.org 827
